Molecular Mechanism of Action of Genistein and Related Phytoestrogens in Estrogen Receptor Dependent and Independent Growth of Breast Cancer Cells
Abstract
During the 3 years of my pre-doctoral research supported by the U.S. Army's Breast Cancer Research Program, I studied estrogen receptor (ER)-dependent and -independent effects of five structurally related phytoestrogens on breast cancer cell growth and apoptosis. Our studies showed that genistein binds to the ER with lower affinity compared to estradiol. However, genistein-bound ER is a 4S monomeric protein, while estradiol-bound ER is multimeric in our sucrose density gradient experiments. We also showed that genistein-ER(beta) complex bound to the consensus estrogen responsive element (ERE) with high affinity. In contrast, genistein bound to ER(alpha) did not significantly bind to the ERE. These results suggest that genistein and estradiol exert different effects on ER-mediated functions. In ER-negative cells, genistein and quercetin inhibited cell growth and induced apoptosis in a dose-dependent manner. Daidzein, kaempferol and biochanin A were less effective. The mechanism of growth inhibition in ER-positive and ER-negative breast cancer cells by genistein and quercetin included G2/M cell cycle arrest and alterations in cyclin B1 protein. Our results suggest that genistein and quercetin may be developed as chemotherapeutic agents against treatment of ER-negative tumors.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jul 01, 2000
- Accession Number
- ADA388980
Entities
People
- Treye Thomas